Norwegian biotech firm Hofseth BioCare (HBC) are to partner up with drug delivery specialists Catalent in an agreement that looks to develop a delayed-release formulation of HBC’s OmeGo salmon oil.
When much of Europe is in lockdown, finding the next step up the career ladder seems like time well spent. As opportunity knocks, NutraIngredients rounds up January’s movers and shakers.
